Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
10/2003
10/08/2003EP1349859A2 Triazolopyrimidines
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349639A1 Method of separating isotopes
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/07/2003US6630557 Tertiary amine methacrylate-based macromonomers and polymers
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2003079983A2 Methods of preparing substituted tetracyclines with transition metal-based chemistries
10/02/2003WO2002055481A8 Prodrugs of excitatory amino acids
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187041 Cardiovascular disorders
10/02/2003US20030187015 Viricides; anticancer agents
10/02/2003US20030186966 Antiinflammatory agents; autoimmune disease; antiallergens
10/02/2003US20030186944 Novel aromatic compounds
10/02/2003CA2780743A1 Substituted tetracycline compounds
10/01/2003EP1348700A2 Composition and method for dyeing dye-susceptible material
10/01/2003EP1347989A1 Bile-acid conjugates for providing sustained systemic concentrations of drugs
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/25/2003WO2003078383A1 Novel positively charged lipids and liposomes comprising the positively charged lipids
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003006489A3 Prodrugs of excitatory amino acids
09/25/2003US20030181765 Reacting an azide compound with an amine to form an intermediate, reducting the azide of the intermediate to form amine; amidation, reduction of azide, azidation, blocking hydroxy group, lactonization and deblocking
09/25/2003US20030181726 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/25/2003US20030181391 Dipeptide apoptosis inhibitors and the use thereof
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003CA2478211A1 Nk1 antagonists
09/24/2003EP1345899A1 Compounds
09/24/2003EP1043308B1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1122021C Amino acid derivatives and their use as pesticides
09/24/2003CN1122020C 3-{N-[2-(N',N'-dimethyl amino oxyethyl group) ethyl]N-methylamino} propionamide used for producing polyurethane
09/24/2003CN1122019C Tetralines bearing phenyl substituant on aromatic ring and their use in treatment of epilepsy, stroke and brain of spinal trauma
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624168 Bactericides, bacteriostats
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6624147 Inhibitors of prenylated pyrophosphate consuming enzymes
09/23/2003US6624142 Trimethyl lock based tetrapartate prodrugs
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/23/2003CA2086654C Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076389A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003US20030176717 Process for the preparation of aryloctanoyl amides
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176510 Acetamidobenzamide compounds for neurodegenerative disorders
09/18/2003US20030176485 Calcium receptor active compounds
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003CA2477949A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/17/2003EP1343810A2 Diaminodicarboxylic acid: peptide-based gemini surfactant compounds used for drug delivery
09/17/2003EP1343805A1 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1230260B1 Hcv ns3 protease inhibitors
09/17/2003EP1229977A4 Polyamide-containing ligands covalently bonded to supports, polyamide-containing resins, and methods for removing metals from solutions
09/17/2003CN1443351A Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition
09/17/2003CN1443154A 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/17/2003CN1121393C Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof
09/17/2003CN1121215C Amino acid derivatives and active oxygen resisting agent
09/12/2003WO2003074990A2 Artificial receptors, building blocks, and methods
09/12/2003WO2003074620A1 Coating composition comprising an acetal-functional binder
09/12/2003CA2477749A1 Artificial receptors, building blocks, and methods
09/11/2003WO2003074449A2 Multi-substitued selective androgen receptor modulators and methods of use thereof
09/11/2003US20030171597 Water solvent is substituted with a linear, branched, or cyclic alcohol having 3 or more carbon atoms; the acid is preferentially precipitated from the alcohol; addition of a base enables purification of the alpha amino amide
09/11/2003US20030171422 Aldose reductase inhibitors; antidiabetic agents
09/11/2003US20030171351 2'-substituted 1,1'-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
09/11/2003US20030171302 Opioid derivative
09/11/2003US20030170917 4-Hydroxyalkylphenethamines, used as an intermediate, hapten, or immunogen in the production of antibodies specific for ecstasy drugs; binding the antibody to the analyte and detecting the adduct formed; immunoassay
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/10/2003EP1150943B1 Preparation of iodixanol
09/10/2003EP1129069B1 Method for the crystallization of iopamidol
09/10/2003EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion
09/10/2003EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
09/10/2003EP0783299B1 Compounds and compositions for delivering active agents
09/10/2003CN1441777A Inhibiting angiogenesis and tumor growth
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors
09/10/2003CN1440962A Substituted amino amide salicylate with Fungal killing function and tis prepared intermediate thereof
09/09/2003US6617425 Of given formula; stable in solution and resistant to proteolytic degradation; use in drug formulations
09/09/2003US6617358 Also bis(optionally chloro- or fluoro-substitutedphenyl)alkylcarboxy acids and esters
09/09/2003US6617333 Antineoplastic combinations comprising
09/09/2003US6617318 7-substitted tetracyclines are effective against tetracycline-resistant E. coli, S. aureus and E. faecalis strains
09/04/2003WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors
09/04/2003WO2003072532A1 Ester compound and medicinal use thereof
09/04/2003WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/04/2003WO2002032376A3 Bile-acid conjugates for providing sustained systemic concentrations of drugs
09/04/2003US20030166952 13-substituted methacycline compounds
09/04/2003US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166693 Benzene derivatives and pharmaceutical use thereof
09/04/2003US20030166691 Phenylalanine derivatives
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 162